Bausch Health this morning updated its conditions on 340B pricing involving deliveries to contract pharmacies to all covered entities. It is the fifth drug maker this month to either impose such conditions for the first time (Organon and
Category: News Alert
Biopharmaceutical manufacturer Exelixis said today it is extending its conditions on 340B pricing to contract pharmacies that are wholly owned or under common ownership with a hospital covered entity. The change is effective June 26.
Exelixis announced the change in
…
Drug manufacturer Teva today became the 23rd drug manufacturer to impose conditions on 340B pricing involving delivery to contract pharmacies.
Covered entities reported getting Teva’s notice by email around 1:00 p.m. Eastern. It said effective July 5:
- Any
Connecticut lawmakers are expected soon to pass a significantly revised version of Gov. Ned Lamont’s (D) health care cost reduction bill stripped of language that would have barred drug manufacturers from limiting use of contract pharmacies and imposing other conditions
…
Drug manufacturer Organon, the Merck spinoff with a focus on women’s health, today became the 22nd drug maker to impose conditions on 340B pricing involving delivery to contract pharmacies.
Covered entities began receiving an email from Organon around 3:00 p.m.
…
Drug manufacturer Novo Nordisk today announced that effective July 1 it will stop letting hospitals place bill to / ship to orders of 340B-purchased drugs to an unlimited number of contract pharmacies in exchange for related claims data.
It will,
…News Alert
Merck Toughens Conditions on 340B Pricing for Hospitals and Health Centers Effective June 12
Drug manufacturer Merck today stiffened its conditions on 340B pricing when hospitals and community health centers use contract pharmacies to dispense most Merck drugs to patients.
Merck told covered entities about the changes in a letter delivered by email
…
Drug manufacturer Bayer this morning significantly tightened its limits on 340B pricing when hospital covered entities contract with pharmacies to dispense drugs to patients. Grantee entities remain exempt from Bayer’s restrictions.
Covered entities reported receiving letters from Bayer about
…
A Virginia Democrat and South Dakota Republican this afternoon reintroduced bipartisan legislation in the U.S. House to protect 340B covered entities and contract pharmacies from discrimination by insurers and pharmacy benefit managers.
Reps. Abigail Spanberger (D-Va.) and Dusty Johnson (R-S.D.)
…